The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer

被引：0
|
作者：
Foresta, A. [1 ]
Colacioppo, P. [1 ]
Baviera, M. [1 ]
Ojeda-Fernandez, L. [1 ]
Cimminiello, C. [2 ]
机构：
[1] Ist Ric Farmacol Mario Negri IRCCS, Lab Cardiovasc Prevent, Milan, Italy
[2] Arianna Fdn Anticoagulat, Bologna, Italy
来源：
THROMBOSIS RESEARCH | 2022年 / 213卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-36
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [21] Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism
    Madridano, Olga
    del Toro, Jorge
    Lorenzo, Alicia
    Martin, Mar
    Gomez Cerezo, Jorge
    Hernandez, Luis
    Prandoni, Paolo
    Monreal, Manuel
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2015, 3 (02) : 135 - +
  • [22] New oral anticoagulant drugs
    Berkovits, Alejandro
    Aizman, Andres
    Zuniga, Pamela
    Pereira, Jaime
    Mezzano, Diego
    REVISTA MEDICA DE CHILE, 2011, 139 (10) : 1347 - 1355
  • [23] Arterial Thromboembolism in Cancer Patients Treated with Apixaban
    Larsen, Trine-Lise
    Brekke, Jorunn
    Garresori, Herish
    Froen, Hege
    Jacobsen, Eva-Marie
    Torfoss, Dag
    Wik, Hilde Skuterud
    Enden, Tone Ronnaug
    Porojnicu, Alina Carmen
    Quist-Paulsen, Petter
    Velle, Elin
    Sandset, Per Morten
    Ree, Anne Hansen
    Dahm, Anders E. A.
    BLOOD, 2022, 140 : 11366 - 11367
  • [24] Risk of arterial thromboembolism in patients with breast cancer
    Navi, B. B.
    Reiner, A. S.
    Kamel, H.
    Iadecola, C.
    Elkind, M. S. V.
    Panageas, K. S.
    DeAngelis, L. M.
    THROMBOSIS RESEARCH, 2016, 140 : S169 - S169
  • [25] Risk of arterial thromboembolism in patients with colorectal cancer
    Navi, Babak B.
    Reiner, Anne S.
    Kamel, Hooman
    Okin, Peter M.
    Iadecola, Costantino
    Elkind, Mitchell S. V.
    Panageas, Katherine
    DeAngelis, Lisa Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] RECENT DATA ON ORAL ANTICOAGULANT TREATMENT IN THROMBOEMBOLISM
    FIESSINGER, JN
    SEMAINE DES HOPITAUX, 1990, 66 (47): : 2680 - 2682
  • [27] Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism
    Masashi Yoshida
    Kentaro Ejiri
    Naoaki Matsuo
    Takanori Naito
    Kazuhiro Kuroda
    Koji Tokioka
    Kunihiko Hatanaka
    Ryohei Fujimoto
    Hidenaru Yamaoka
    Yutaka Kajikawa
    Kazuki Suruga
    Hiroki Sugiyama
    Tsuyoshi Miyaji
    Yoshimasa Morimoto
    Nobuhiro Okamura
    Toshihiro Sarashina
    Satoshi Akagi
    Toru Miyoshi
    Kazufumi Nakamura
    Hiroshi Ito
    Shinsuke Yuasa
    Thrombosis Journal, 23 (1)
  • [28] VENOUS THROMBOEMBOLISM, ORAL CONTRACEPTION AND THE LUPUS ANTICOAGULANT
    BUCK, ME
    FARQUHARSON, RG
    PEARSON, JF
    WILLIAMS, BD
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 7 (04) : 290 - 290
  • [29] Safety of Anticoagulant Therapies for Treatment of Venous Thromboembolism in Patients with Cancer
    Streiff, Michael
    Milentijevic, Dejan
    McCrae, Keith
    Yannicelli, Daniel
    Fortier, Jonathan
    Nelson, Winnie
    Laliberte, Francois
    Crivera, Concetta
    Lefebvre, Patrick
    Schein, Jeff
    Khorana, Alok A.
    BLOOD, 2016, 128 (22)
  • [30] Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
    Toth, Peter P.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 23 - 34
12345